A recent survey in the United States has found that injected weight loss drugs are still preferred by physicians over newer oral treatments – by a significant margin – with Eli Lilly’s Zepbound topping the charts, reports Fierce Pharma. According to healthcare specialists Spherix Global Insights, the poll, with input from 185 American specialists, showed … Continue reading Zepbound injectable remains doctors’ favourite, despite oral options